Included in this section:
ACORD Trial: Treatment Study for No-Option Heart Patients with Coronary Artery Disease: Injections into the heart with a human recombinant (protein) fibroblast growth factor (FGF- investigational compound) compared to placebo. The goal is to stimulate the growth of new blood vessels around blocked coronary arteries.
ACT 1 Investigational Carotid Stenosis Trial: ACT 1 investigational trial for patients with asymtomatic carotid stenosis
APPRAISE-2: Examination of Apixaban for Acute Coronary Syndrome: Examination of Apixaban (Factor Xa inhibitor) compared to placebo as adjunctive therapy in patients with recent Acute Coronary Syndrome
Carotid Artery Stenosis Study: Carotid RX ACCULINK/RX ACCUNET postapproval trial to uncover unanticipated and rare events (CAPTURE 2)
Diet Study: Effect of a Severely Restricted Carbohydrate Diet As Compared to the TLC Diet on Triglyceride Levels in Hypertriglyceridemic Subjects
Electrophysiology (Early Repolarization): Early Repolarization Study
GORE Reduce Study: GORE HELEX" Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA
Investigational mechanical circulatory support device for heart transplant candidates: Investigation of a mechanical device that provides circulatory support as a bridge to cardiac transplant in patients who are at risk of imminent death from nonreversible left ventricular failure.
Left Ventricular Assist Device Study: Study of new third generation left ventricular assist device
Longitudinal Study of Beta Blocker Utilization in Patients with Heart Failure: Longitudinal study of beta blocker utilization in patients with heart failure
Making Health Care Decisions: How people make health care decisions to treat chronic health conditions
Marvel Stem Cell Treatment Study: Study of a stem cell treatment using an investigational injection catheter in post MI congestive heart failure patients.
Miniaturized Percutaneous Circulatory Support System vs IABP (Impella): Impella investigational trial for non-emergent high-risk PCI patients.
Novel Peripheral Arterial Disease (PAD) Study: Novel investigational therapy for the treatment of intermittent claudication for those who suffer from Peripheral Arterial Disease (PAD).
Osiris PROCHYMAL® Stem Cell Treatment Study: Study of PROCHYMAL® (cultured adult human mesenchymal stem cells) administration to preserve or improve cardiac function following heart attack
|